Shrividya Iyer - Concepedia

Author

Shrividya Iyer

Also Known As

Jonathan De Courcy, S Iyer, S. IYER, S. Iyer, S. Subramonia Iyer, Shrividya Iyer, Shrividya S. Iyer, Siddesh Mahadev Iyer, Subramaniam Seshan Iyer, Suchi Iyer

114

Publications

9.8K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Seoul National University Hospital Pfizer (Italy)RTI Health Solutions Peter MacCallum Cancer Centre

About

Shrividya Iyer is an author at Pfizer (United States) specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.2K
2	Health Sciences	7	7	278
3	Business	2	2	34
4	Management	2	2	34
5	Nursing	1	1	25

Shrividya Iyer

Publications

9.7K

Citations

H-Index

Page 1

	Year	Citations
Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer Alice T. Shaw, Dong‐Wan Kim, Kazuhiko Nakagawa, New England Journal of Medicine	2013	3.4K
First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer Benjamin Solomon, Tony Mok, Dong‐Wan Kim, New England Journal of Medicine	2014	3.2K
Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up Hope S. Rugo, Richard S. Finn, Véronique Dièras, Breast Cancer Research and Treatment	2019	415
Economic Burden of Postoperative Ileus Associated With Colectomy in the United States Shrividya Iyer, W. Brian Saunders, Stephen Stemkowski Journal of Managed Care Pharmacy	2009	334
The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study Shrividya Iyer, Adam Roughley, A. Rider, Supportive Care in Cancer Symptom BurdenTobacco ControlCancer ScreeningMedicineEpidemiology Of Cancer	2013	216
Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany Shrividya Iyer, Gavin Taylor‐Stokes, Adam Roughley Lung Cancer Palliative CareTobacco ControlQuality Of LifeSymptom BurdenLife Assessment	2013	192
Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial Nadia Harbeck, Shrividya Iyer, Nicholas C. Turner, Annals of Oncology	2016	173
Results of a global phase II study with crizotinib in advanced <i>ALK</i>-positive non-small cell lung cancer (NSCLC). Dong‐Wan Kim, Myung‐Ju Ahn, Yuankai Shi, Journal of Clinical Oncology Tumor ResponseMedicineCancer ManagementMetronomic TherapyPharmacology	2012	159
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Patients With Chronic, Nonmalignant Pain: A Randomized Controlled Study Edward Michna, E. Richard Blonsky, Seth L. Schulman, Journal of Pain Health SciencesAddictionPain MedicineMedicinePostoperative Pain Management	2011	153
Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial Hope S. Rugo, Véronique Dièras, Karen A. Gelmon, Annals of Oncology	2018	149

Page 1